Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Axonal Loss in a Rat Model of Optic Neuritis Is Closely Correlated with Visual Evoked Potential Amplitudes Using Electroencephalogram-based Scaling.
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
Coping strategies and mood profiles in patients with multiple sclerosis.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Treatment of HIV and Risk of Multiple Sclerosis.
Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review.
Peripheral neuropathy associated with mitochondrial disease in children.
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy.
Animal assisted interventions in neurorehabilitation: A review of the most recent literature.
Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.
[Prevention of multiple sclerosis: A realistic goal?]
Merck KGaA to try again to get approval for MS pill cladribine
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Secukinumab: first global approval.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
The recurrent Guillain-Barré syndrome: a long-term population-based study.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
Top 10 Research Questions Related to Physical Activity and Multiple Sclerosis.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption.

Pages